Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study

Background: Omalizumab may modulate airway remodeling in severe asthma. Using forced expiratory volume in 1 second (FEV 1 ) as a surrogate of airway remodeling, we aimed to investigate if an omalizumab add-on in severe allergic asthma may lead to a persistent reversal of airway obstruction and to ev...

Full description

Bibliographic Details
Main Authors: Paolo Solidoro, Filippo Patrucco, Francesca de Blasio, Luisa Brussino, Michela Bellocchia, Davide Dassetto, Emanuele Pivetta, Annamaria Riccio, Enrico Heffler, Walter Canonica, Giovanni Rolla, Caterina Bucca
Format: Article
Language:English
Published: SAGE Publishing 2019-04-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/1753466619841274